Primary vaccination and revaccination of young adults with BCG: A study using immunological markers

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 9, 2007, Pages 792-798

  Fjällbrant, Harald ^a   Ridell, Malin ^a   Larsson, Lars Olof ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BCG VACCINATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; HEALTH CARE POLICY; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION RESISTANCE; LYMPHOCYTE TRANSFORMATION; MALE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; REVACCINATION; RISK ASSESSMENT; TH1 CELL; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; BCG VACCINE; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548119200     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701367777     Document Type: Article

References (27)

1. Clements, CJ. (2003) Vaccination: The current status of BCG. Mycobacteria and TB. Karger, pp. 46-66.
2. Springett, VH and Sutherland, I. (1994) A re-examination of the variations in the efficacy of BCG vaccination against tuberculosis in clinical trials. Tuber Lung Dis, 75, pp. 227-233.
3. Kubit, S., Czajka, S., Olakowski, T. and Piasecki, Z. (1983) Effectiveness of BCG vaccination. Pediatr Pol, 58, pp. 775-781.
4. Tala-Heikkila, MM, Tuominen, JE and Tala, EO. (1998) Bacillus Calmette-Guerin revaccination questionable with low tuberculosis incidence. Am J Respir Crit Care Med, 157, pp. 1324-1327.
5. Barbosa, T., Arruda, S., Fernandes, BD, Carvalho, LP, Cardoso, S. and Cunha, S. (2003) BCG (Bacille of Calmette-Guerin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children. Vaccine, 21, pp. 2152-2160.
6. Nabeshima, S., Murata, M., Yamaji, K., Chong, Y., Nomoto, M. and Hayashi, J. (2005) Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production by PBMC in adults after BCG vaccination. J Infect Chemother, 11, pp. 18-23.
7. Rodrigues, LC, Pereira, SM, Cunha, SS, Genser, B., Ichihara, MY and de Brito, SC (2005) Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: The BCG-REVAC cluster-randomized trial. Lancet, 366, pp. 1290-1295.
8. Hoft, DF, Kemp, EB, Marinaro, M., Cruz, O., Kiyono, H. and McGhee, JR (1999) A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guerin vaccination. J Lab Clin Med, 134, pp. 244-252.
9. Black, GF, Weir, RE, Floyd, S., Bliss, L., Warndorff, DK and Crampin, AC (2002) BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: Two randomized controlled studies. Lancet, 359, pp. 1393-1401.
10. Weir, RE, Black, GF, Nazareth, B., Floyd, S., Stenson, S. and Stanley, C. (2006) The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to Bacille Calmette-Guerin vaccination in southern England and northern Malawi. Clin Exp Immunol, 146, pp. 390-399.
11. Ravn, P., Boesen, H., Pedersen, B Klarlund and Andersen, P. (1997) Human T-cell responses induced by vaccination with Mycobacterium bovis Bacille Calmette-Guérin. J Immunol, 158, pp. 1949-1955.
12. Flynn, JF. (2004) Immunology of tuberculosis and implications in vaccine development. Tuberculosis, 84, pp. 93-101.
13. Barnes, P. and Vankayalapati, R. (2005) Th1 and Th2 cytokines in the human immune response to tuberculosis. Tuberculosis and the tubercle bacillus, pp. 489-496. ASM press, Washington, DC
14. Leal, IS, Florido, M., Andersen, P. and Appelberg, R. (2001) Interleukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccine. Immunology, 103, pp. 375-381.
15. De Jager, W., Velthuis, H te, Prakken, BJ, Kuis, W. and Rijkers, GT. (2003) Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol, 10, pp. 133-139.
16. Hoft, DF, Worku, S., Kampmann, B., Whalen, CC, Ellner, JJ and Hirsch, CS (2002) Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis, 186, pp. 1448-1457.
17. Mawa, PA, Pickering, JM, Miiro, G., Namujju, PB, Watera, C. and Anyaegani, G. (2004) The effect of tuberculin skin testing on viral load and anti-mycobacterial immune responses in HIV-1-infected Ugandan adults. Int J Tuberc Lung Dis, 8, pp. 586-592.
18. Rosenthal, SR. (1980) Resistance to tuberculosis in man. BCG vaccine: tuberculosis-cancer, pp. 220-252. PSG Publishing Company, Littleton, Massachusetts
19. Greenberg, PD, Lax, KG and Schechter, CB. (1991) A decision analysis comparing the tuberculin screening strategy with the BCG vaccination. Am Rev Respir Dis, 143, pp. 490-495.
20. Bloom, BR and Fine, PEM (1994) Tuberculosis pathogenesis protection and control, pp. 531-557. ASM Press, Washington, DC
21. Soysal, A., Millington, KA, Bakir, M., Dosanjh, D., Aslan, Y. and Deeks, JJ (2005) Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet, 366, pp. 1443-1451.
22. Lopez, B., Aguilar, D., Orozco, H., Burger, M., Espitia, C. and Ritacco, V. (2003) A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol, 133, pp. 30-37.
23. Brudey, K., Gordon, M., Moström, P., Svensson, L., Jonsson, B. and Sola, C. (2004) Molecular epidemiology of Mycobacterium tuberculosis in western Sweden. J Clin Microbiol, 42, pp. 3046-3051.
24. Sterne, JA, Rodrigues, LC and Guedes, IN. (1998) Does the efficacy of BCG decline with time since vaccination?. Int J Tuberc Lung Dis, 2, pp. 200-207.
25. Cheon, SH, Kampmann, B., Hise, AG, Phillips, M., Song, HY and Landen, K. (2002) Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis. Clin Diagn Lab Immunol, 9, pp. 901-907.
26. Cunha, AJ, Sant'Anna, CC, Mannarino, R., Labanca, TC, Ferreira, S. and March, MF. (2002) Adverse effects of BCG revaccination: A report on 13 cases from Rio de Janeiro, Brazil. Int J Tuberc Lung Dis, 6, pp. 1110-1113.
27. Arantes, GR. (1980) Post-vaccinal tuberculin sensitivity and its irrelevance to BCG revaccination. Rev Saude Publica, 14, pp. 234-245.